Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel W Miller

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Healthcare (Basel, Switzerland)|July 7, 2019
Clinical Factors Associated with Longer Hospital Stay Following Ovarian Cancer SurgeryChristopher G Smith, Daniel L Davenport, Justin Gorski, et al.
JCO Precision Oncology|September 14, 2022
Molecular Tumor Board-Assisted Care in an Advanced Cancer Population: Results of a Phase II Clinical TrialRachel W Miller, Megan L Hutchcraft, Heidi L Weiss, et al.
Diagnostics (Basel, Switzerland)|January 25, 2020
Disease-Specific Survival of Type I and Type II Epithelial Ovarian Cancers-Stage Challenges Categorical Assignments of Indolence & AggressivenessEdward J Pavlik, Christopher Smith, Taylor S Dennis, et al.
Diagnostics (Basel, Switzerland)|January 21, 2022
Significance of Pelvic Fluid Observed during Ovarian Cancer Screening with Transvaginal SonogramJustin W Gorski, Charles S Dietrich, Caeli Davis, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Healthcare (Basel, Switzerland)|July 7, 2019
Clinical Factors Associated with Longer Hospital Stay Following Ovarian Cancer SurgeryChristopher G Smith, Daniel L Davenport, Justin Gorski, et al.
JCO Precision Oncology|September 14, 2022
Molecular Tumor Board-Assisted Care in an Advanced Cancer Population: Results of a Phase II Clinical TrialRachel W Miller, Megan L Hutchcraft, Heidi L Weiss, et al.
Diagnostics (Basel, Switzerland)|January 25, 2020
Disease-Specific Survival of Type I and Type II Epithelial Ovarian Cancers-Stage Challenges Categorical Assignments of Indolence & AggressivenessEdward J Pavlik, Christopher Smith, Taylor S Dennis, et al.
Diagnostics (Basel, Switzerland)|January 21, 2022
Significance of Pelvic Fluid Observed during Ovarian Cancer Screening with Transvaginal SonogramJustin W Gorski, Charles S Dietrich, Caeli Davis, et al.
Pageof 4